Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 3,131 | 0 | 0 | 0 | 0 |
| Gross Profit | 3,131 | N/A | N/A | N/A | N/A |
| Operating Expenses | 36,958 | 31,966 | 27,807 | 26,089 | 22,918 |
| Operating Income | -33,827 | -30,888 | -27,807 | -26,089 | -22,918 |
| Other Income | -800 | 94 | -44 | -6 | 17 |
| Pre-tax Income | -34,627 | -30,794 | -27,851 | -26,095 | -22,901 |
| Net Income Continuous | -34,627 | -30,794 | -27,851 | -26,095 | -22,901 |
| Net Income | $-34,627 | $-30,794 | $-27,851 | $-26,095 | $-22,901 |
| EPS Basic Total Ops | -0.73 | -0.68 | -0.73 | -0.70 | -0.69 |
| EPS Basic Continuous Ops | -0.73 | -0.68 | -0.73 | -0.70 | -0.69 |
| EPS Diluted Total Ops | -0.73 | -0.68 | -0.73 | -0.70 | -0.69 |
| EPS Diluted Continuous Ops | -0.73 | -0.68 | -0.73 | -0.70 | -0.69 |
| EBITDA(a) | $-33,265 | $-31,545 | $-27,508 | $-25,772 | $-22,611 |